Colinz Laboratories share news and announcements
BSE: 531210Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹67.00.
- Next results date: the board meets on 29 Oct 2026 to consider: quarterly results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹17 Cr4,457th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 30 Jul 2026
- 6.1
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹2.76 crore of one-off items, the largest of them in the quarter to Jun 2026.
- 512.2
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 29 Apr 2026
- 1.7
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 30 Jul 2026
- 28.7%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹2.76 crore of one-off items, the largest of them in the quarter to Jun 2026.
- 0.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 30 Jul 2026
- 1.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 29 Apr 2026
- 0.04
- Volume, BSEVolume. Shares traded on the last trading day.
- 4,440
Colinz Laboratories share news and announcements
436 announcements, routine notices left out, newest first. Page 4 of 9.
Aug 2023
Jul 2023
14 Jul · Board meeting
Meeting on 31 Jul 2023: quarterly results6 Jul · Announcement Under Regulation 30 -Availing Exemption Under Various Provisions Under Regulation 15(2) In Compliance Of Various Clauses Pf Corporate Governance
May 2023
27 May · In Terms Of Provisions Of Regulation 30 (Read With Part A Of Schedule III) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), This Is To Inform You That The Board Of Directors, At Its Meeting Held Today, I.E., 27Th May, 2023, Has Inter Alia Transacted The Following Business Items :
3 May · Board meeting
Meeting on 27 May 2023: audited results1 May · Declaration With Respect To Non-Applicability Of Related Party Transactib.Rt Flrr.Tornt To Regulations 23(9) Of The Sebi Flisting Obligations And Disclosure Requirements, L Regulation 2015).
Apr 2023
14 Apr · Compliance Certificate Under Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Jan 2023
12 Jan · Board meeting
Meeting on 28 Jan 2023: quarterly results
Oct 2022
17 Oct · Board meeting
Meeting on 31 Oct 2022: quarterly results10 Oct · Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Sep 2022
30 Sep · Meeting
Aug 2022
Jul 2022
14 Jul · Board meeting
Meeting on 30 Jul 2022: quarterly results11 Jul · Statement Of Investor Complaints For The Quarter Ended June 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 05 Jul · Announcement Under Regulation 30 - Availing Exemption Under Various Provisions Under Regulation 15(2) In Respect Of Compliance Of Various Clauses Of Corporate Governance
May 2022
16 May · Board meeting
Meeting on 28 May 2022: audited results and quarterly results
Apr 2022
12 Apr · Sub : Certificate From Practicing Company Secretary Under Regulation 40(9) Of SEBI(LODR),2015
12 Apr · Sub: Compliance Certificate Under Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
8 Apr · Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 01 Apr · Board meeting
Meeting on 15 Apr 2022
Feb 2022
18 Feb · Board meeting
Meeting on 28 Feb 2022